​
​

Q32 Bio (FIXX) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Q32 Bio Revenue Highlights

Latest Revenue (Y)

$1.16M

0

Q32 Bio Revenue by Period

Q32 Bio Revenue by Year

DateRevenueChange
2023-12-31$1.16M-63.97%
2022-12-31$3.21M-90.56%
2021-12-31$33.97M1157.25%
2020-12-31$2.70M62.18%
2019-12-31$1.67M-54.78%
2018-12-31$3.68M100.00%
2017-12-31-100.00%
2016-12-31--

Q32 Bio generated $1.16M in revenue during NA 2023, up -63.97% compared to the previous quarter, and up 31.38% compared to the same period a year ago.

Q32 Bio Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$1.42M100.00%
2023-09-30--100.00%
2023-06-30$354.00K-55.86%
2023-03-31$802.00K-
2022-12-31$802.00K-
2022-09-30$802.00K-
2022-06-30$802.00K-
2022-03-31$802.00K-
2021-12-31$802.00K-52.18%
2021-09-30$1.68M-23.32%
2021-06-30$2.19M-92.54%
2021-03-31$29.30M2890.31%
2020-12-31$980.00K72.84%
2020-09-30$567.00K-
2020-06-30$567.00K-3.57%
2020-03-31$588.00K4.44%
2019-12-31$563.00K27.66%
2019-09-30$441.00K12.50%
2019-06-30$392.00K45.19%
2019-03-31$270.00K-72.45%
2018-12-31$980.00K2.71%
2018-09-30$954.15K2.99%
2018-06-30$926.48K12.52%
2018-03-31$823.37K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Q32 Bio generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Q32 Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAPAdaptimmune Therapeutics$60.28M$128.23M
STOKStoke Therapeutics$8.78M$4.89M
FIXXQ32 Bio$1.16M-
BCELAtreca$770.00K$80.00K
BDTXBlack Diamond Therapeutics--
PASGPassage Bio--
FDMT4D Molecular Therapeutics--

FIXX Revenue FAQ

What is Q32 Bio’s yearly revenue?

Q32 Bio's yearly revenue for 2023 was $1.16M, representing a decrease of -63.97% compared to 2022. The company's yearly revenue for 2022 was $3.21M, representing a decrease of -90.56% compared to 2021. FIXX's yearly revenue for 2021 was $33.97M, representing an increase of 1157.25% compared to 2020.

What is Q32 Bio’s quarterly revenue?

Q32 Bio's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.42M, a 100.00% increase from the previous quarter (Q3 2023), and a 76.81% increase year-over-year (Q4 2022). FIXX's quarterly revenue for Q3 2023 was $0, a -100.00% decrease from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).

What is Q32 Bio’s revenue growth rate?

Q32 Bio's revenue growth rate for the last 3 years (2021-2023) was -96.60%, and for the last 5 years (2019-2023) was -30.61%.